The microglia receptors CD33 and triggering receptor expressed on myeloid cells 2 (TREM2) regulate neuroinflammation and are therapeutic targets in AD (Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013). Here, CD33 is linked to Alzheimer disease.